Connection

Timothy Lyons to Oxidation-Reduction

Back to Details
This is a "connection" page, showing publications Timothy Lyons has written about Oxidation-Reduction.
Timothy Lyons
Connection Strength
0.557
Oxidation-Reduction
  1. Survival or death: a dual role for autophagy in stress-induced pericyte loss in diabetic retinopathy. Diabetologia. 2016 10; 59(10):2251-61.
    View in: PubMed
    Score: 0.119
  2. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol. 1993 Feb 25; 71(6):26B-31B.
    View in: PubMed
    Score: 0.094
  3. Oxidative and endoplasmic reticulum stresses mediate apoptosis induced by modified LDL in human retinal M?ller cells. Invest Ophthalmol Vis Sci. 2012 Jul 09; 53(8):4595-604.
    View in: PubMed
    Score: 0.090
  4. Intraretinal leakage and oxidation of LDL in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2008 Jun; 49(6):2679-85.
    View in: PubMed
    Score: 0.067
  5. Aminoguanidine and the effects of modified LDL on cultured retinal capillary cells. Invest Ophthalmol Vis Sci. 2000 Apr; 41(5):1176-80.
    View in: PubMed
    Score: 0.038
  6. Pre-enrichment of modified low density lipoproteins with alpha-tocopherol mitigates adverse effects on cultured retinal capillary cells. Curr Eye Res. 1999 Aug; 19(2):137-45.
    View in: PubMed
    Score: 0.037
  7. Glycation, oxidation, and glycoxidation reactions in the development of diabetic complications. Contrib Nephrol. 1995; 112:1-10.
    View in: PubMed
    Score: 0.027
  8. Increased methionine sulfoxide content of apoA-I in type 1 diabetes. J Lipid Res. 2008 Apr; 49(4):847-55.
    View in: PubMed
    Score: 0.016
  9. In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetes. Metabolism. 2004 Aug; 53(8):969-76.
    View in: PubMed
    Score: 0.013
  10. Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells. Diabetes. 2000 Dec; 49(12):2160-9.
    View in: PubMed
    Score: 0.010
  11. Carboxymethylethanolamine, a biomarker of phospholipid modification during the maillard reaction in vivo. J Biol Chem. 1997 Jul 11; 272(28):17473-9.
    View in: PubMed
    Score: 0.008
  12. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem J. 1997 Feb 15; 322 ( Pt 1):317-25.
    View in: PubMed
    Score: 0.008
  13. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem. 1996 Apr 26; 271(17):9982-6.
    View in: PubMed
    Score: 0.007
  14. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes. 1994 May; 43(5):676-83.
    View in: PubMed
    Score: 0.006
  15. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest. 1993 Jun; 91(6):2463-9.
    View in: PubMed
    Score: 0.006
  16. Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry. 1991 Feb 05; 30(5):1205-10.
    View in: PubMed
    Score: 0.005
  17. Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes. 1991 Feb; 40(2):190-6.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.